Dr. Johan Vanden Broucke SRL
Dr. Johan Vanden Broucke reported total assets of €1.88m at the end of the 2025 financial year (annual accounts filed with the NBB on 27 Aug 2026).
By total assets for 2025, Dr. Johan Vanden Broucke ranks in the top half of the 993 companies in its sector (NACE 7210) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Dr. Johan Vanden Broucke shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +3 % Total assets +2 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Dr. Johan Vanden Broucke's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 27 Aug 2026
- Year ended 31 Dec 2024filed on 31 Aug 2025
- Year ended 31 Dec 2023filed on 31 Aug 2024
- Year ended 31 Dec 2022filed on 01 Aug 2023
- Year ended 31 Dec 2021filed on 31 Aug 2022
Dr. Johan Vanden Broucke's financial analysis
- Solvency94.2%sector median: 60.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Dr. Johan Vanden Broucke
Dr. Johan Vanden Broucke's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0479.040.735
- VAT number
- BE0479040735
- Peppol
- Registered · 0208:0479040735 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 16 Dec 2002
- Registered office
- 8904 Ypres
- Latest accounts
- 2025 · filed on 27 Aug 2026
- Activity
- Research and experimental development on biotechnology (NACE 72101)
Dr. Johan Vanden Broucke (SRL) has been based in Ypres since 2002, active in: research and experimental development on biotechnology. For 2025, it reports a net profit of 392,670 € and equity of €1.78m; its revenue is not published. Its solvency stands at 94.2%, above the median of its sector (60.4%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Dr. Johan Vanden Broucke
Companies in the same business, of comparable size and area, outside its group.
- Axis44 Research and experimental development on natural sciences and engineering Jodoigne · balance sheet €2.45m
- ProtonW.be Research and experimental development on natural sciences and engineering Charleroi · balance sheet €1.27m
- Nyemb Research and experimental development on natural sciences and engineering Tournai · balance sheet €1.15m
- CTTec Research and experimental development on natural sciences and engineering Menen · balance sheet 259,750 €
- Drs Pipeleers & Marichal Research and experimental development on natural sciences and engineering Roosdaal · balance sheet €2.05m
- Dokter Fries Claerhout Research and experimental development on natural sciences and engineering Poperinge · balance sheet 906,181 €
- IR 4 Research and experimental development on natural sciences and engineering Auderghem · balance sheet 865,084 €
- Oncoradiomics Research and experimental development on natural sciences and engineering Liège · balance sheet €4.31m
Frequently asked questions about Dr. Johan Vanden Broucke
What is the revenue of Dr. Johan Vanden Broucke?
Dr. Johan Vanden Broucke files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Dr. Johan Vanden Broucke?
In Belgium, the VAT number is the company number prefixed with BE: BE0479040735 for Dr. Johan Vanden Broucke, if the company is VAT-registered. Its company number (CBE) is 0479.040.735.
Where is the registered office of Dr. Johan Vanden Broucke?
According to the CBE register, the registered office of Dr. Johan Vanden Broucke is in 8904 Ypres.
What is the equity of Dr. Johan Vanden Broucke?
At the close of the 2025 financial year, the equity of Dr. Johan Vanden Broucke amounts to 1,775,708 €, a solvency of 94.2% of total assets.
Who manages Dr. Johan Vanden Broucke?
The register lists 1 active mandates at Dr. Johan Vanden Broucke. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Dr. Johan Vanden Broucke within its sector?
By total assets for 2025, Dr. Johan Vanden Broucke ranks in the top half of the 993 companies in its sector (NACE 7210) in Belgium that filed accounts for that financial year.
The full file of Dr. Johan Vanden Broucke
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →